CIA is one of the most secret departments of the US government, and even in relation to this department, decisions on information disclosure are periodically made. This is required by the US Constitution and a number of federal laws.
For example, Bill Clinton’s 1995 presidential decree ordered the Central Intelligence Agency to disclose archival information from the Cold War, Vietnam and Korean conflicts. By early 2017, the CIA had reported that the 1995 presidential decree had been implemented. During two decades, 775 thousand documents on 13 million pages have been posted online.
As for the civilian departments of the United States, their activities should be as transparent as possible. This is required, first of all, by the Freedom of Information Act (FOIA), signed by President Lyndon B. Johnson on July 4, 1966 and entered into force the following year.
U.S. agencies such as the Department of Health and Human Services (HHS), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC), work closely with private drug companies (pharmaceutical industry) and provide a variety of medical services (private medicine). It is not a secret for anyone that informal relations have been established between government departments and private businesses engaged in the production of pharmaceutical products and the provision of medical services. And this, in turn, sharply reduces the transparency of the activities of both government agencies and private companies in the field of pharmacology and private medical services. The events associated with the “pandemic” led that fact.
Here is one of the latest examples of secrecy, unexpected for many Americans, in connection with the coronavirus vaccination unfolding in the country. A group called Public Health and Medical Professionals for Transparency (PHMPT) filed a lawsuit on September 16, 2021 in the US District Court for the Northern District of Texas. Medical scientists are seeking from the FDA to open all data on the Pfizer vaccine against COVID-19. The release of such information could help convince vaccine-distrusting skeptics that the drug is indeed “safe and effective, which will increase the credibility of the Pfizer vaccine,” they said.
Plaintiffs were still willing to accept Pfizer’s status as an “experimental” emergency drug (EUA). American laws prescribe the procedure for using drugs that have not passed the required cycle of clinical trials. However, the plaintiffs were very confused by the fact that on the 23rd of August this year, the Pfizer drug (Comirnaty trademark) received the status of a full-fledged vaccine that can be used to vaccinate people aged 16 and older. The initiative stems from the overwhelming number of reported “side effects” and even deaths following the use of Pfizer vaccine.
The PHMPT group is made up of more than 30 professors and medical scientists from Yale, Harvard, California and Los Angeles Universities, as well as Brown University. Here are the first names on the list of signatories to the claim: Psychiatrist Professor Aaron Kheriaty; Professor of Epidemiology Harvey Risch; Peter A. McCullough, professor of epidemiology and cardiology.
The respondent (FDA) surprised everyone with their answer. The FDA said that it would take 55 years to fully publish all these documents. And if the district judge in Texas supports the defendant, then the plaintiffs will be able to obtain this data only in 2076. Specialists from the Department of Justice, representing the interests of the FDA, note that the volume of materials related to the vaccine is about 329 thousand pages and the FDA can’t just release documents to the public.
The records must be scrutinized to edit “Pfizer’s or BioNTech’s confidential trade and business secrets and the personal confidential information of patients who participated in clinical trials,” the Justice Department lawyers write.
The plaintiffs’ legal advisors are Aaron Siri of Siri & Glimstad in New York and John Howie of Howie Law in Dallas. Aaron Siri has extensive experience in complex civil litigation, including compulsory medicine civil rights. Aaron Siri has long represented people affected by vaccines. He recently said in a US panel discussion led by Senator Ron Johnson that during the COVID crisis, an astronomical number of inquiries were received on the law firm’s phones. Aaron added that there are simply not so many lawyers in America today who could immediately take on this array of vaccine complaints.
The plaintiffs’ lawyers believe their request should be the FDA’s highest priority. They insist on the publication of all materials no later than March 3, 2022, because, according to the plaintiffs, it should not take more time to disclose the documents than to study them.
“108 days was the time it took the FDA to review the relevant documents for the much more difficult task of approving the Pfizer COVID-19 vaccine,” the lawyers write.
The plaintiff scholars have already hit the spotlight in the press. When commenting on their initiative, they admitted that they have serious suspicions about the Pfizer drug and that their statement of claim is the minimum requirement for the company and the pharmaceutical regulator. If the FDA continues to insist that disclosures can continue for 55 years, then there is no doubt that the government is protecting pharmaceutical vaccine companies from any liability for harm to human health.
There is no final judgment on the PHMPT claim. The FDA has begun issuing scarce information. The first “data glimpse” was on November 17 – two months after the filing of the claim and almost three months after Pfizer was fully legalized as a “vaccine.” About 100 pages in total.
Attorney Aaron Siri published his first report on information he received from the FDA. It turns out that by February 28, just two and a half months after the drug received an “emergency use” approval (EUA) from the FDA, Pfizer had received a total of 42,086 user reports from the drug. A total of 158,893 cases of “side effects” were recorded in them. Most of these reports were from the United States, with a disproportionate number of women (29,914 versus 9,182 reported by men) and those from the 31-50 age group (13,886 versus 21,325 for all other age groups combined). 25,957 cases were classified as “nervous system disorders”.
Pfizer’s filings with the FDA record:
“Due to the high number of reported spontaneous adverse events reported with the product, [Pfizer] is prioritizing serious case analysis …” [Pfizer] “also took a number of actions to help reduce the significant increase in reported side effects ”(including“ an increase in the number of informants involved in data entry and case management”).
The company “has recruited approximately [REDACTED] additional full-time employees.” Lawyer Aaron Siri wonders why the company should consider it a secret how many people Pfizer had to hire to track down all the adverse side effects reported shortly after the launch of its product. Their efforts, most likely, were not aimed at making changes to the drug itself, but at reducing the number of “negative” reports.
The second “data glimpse” was presented on December 1, and was surprisingly in a smaller volume than the first.
The FDA (apparently under pressure from Pfizer) is seeking to increase the disclosure period of information provided by the pharmaceutical company to the agency within a few months from 55 to 75 years. That is, the claim of the plaintiff will be fully satisfied only by 2096.